Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5081803
Max Phase: Preclinical
Molecular Formula: C18H23F2N
Molecular Weight: 291.38
Molecule Type: Unknown
Associated Items:
ID: ALA5081803
Max Phase: Preclinical
Molecular Formula: C18H23F2N
Molecular Weight: 291.38
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc1ccc(C(F)F)cc13
Standard InChI: InChI=1S/C18H23F2N/c1-21-9-8-18-7-3-2-4-14(18)16(21)11-12-5-6-13(17(19)20)10-15(12)18/h5-6,10,14,16-17H,2-4,7-9,11H2,1H3/t14-,16+,18+/m1/s1
Standard InChI Key: ISRLNSUYNQXWKJ-HFTRVMKXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 291.38 | Molecular Weight (Monoisotopic): 291.1799 | AlogP: 4.31 | #Rotatable Bonds: 1 |
Polar Surface Area: 3.24 | Molecular Species: BASE | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.87 | CX LogP: 4.04 | CX LogD: 1.60 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: 0.75 |
1. Sorrentino JP, Altman RA.. (2022) Fluoroalkylation of Dextromethorphan Improves CNS Exposure and Metabolic Stability., 13 (4.0): [PMID:35450379] [10.1021/acsmedchemlett.2c00055] |
Source(1):